乳腺癌组织及间质浸润淋巴细胞中PD-L1的表达及其意义
发布时间:2018-12-21 20:14
【摘要】:目的探讨程序性死亡配体-1(programmed death ligand-1,PD-L1)在乳腺癌组织及间质浸润淋巴细胞(stromal tumor-infiltrating lymphocyte,sTIL)中的表达及其与临床病理特征的关系。方法收集68例乳腺非特殊性浸润性癌,采用免疫组化EliVision两步法检测PD-L1蛋白表达,并分析其与免疫组化亚型及临床病理特征的关系。结果乳腺肿瘤细胞中PD-L1总阳性率为35.3%,尤其在三阴型乳腺癌肿瘤细胞中的阳性率最高,在管腔型、HER-2过表达型及三阴型乳腺癌肿瘤细胞中的阳性率分别为16.1%、37.5%、61.9%,差异有统计学意义。PD-L1在sTIL中的总阳性率为51.5%,且在三阴型乳腺癌中最高,阳性率为81.0%;PD-L1在管腔型、HER-2过表达型及三阴型乳腺癌sTIL中的表达差异具有统计学意义。PD-L1在乳腺癌与sTIL中的表达呈正相关。结论 PD-L1在三阴型乳腺癌中表达明显高于其他类型乳腺癌,阻断PD-L1/PD-1信号通路,有望成为乳腺癌尤其是三阴型乳腺癌免疫治疗的新策略。
[Abstract]:Objective to investigate the expression of programmed death ligand 1 (programmed death ligand-1,PD-L1 in breast cancer tissues and interstitial infiltrating lymphocytes (stromal tumor-infiltrating lymphocyte,sTIL) and its relationship with clinicopathological features. Methods 68 cases of nonspecific invasive breast carcinoma were collected. The expression of PD-L1 protein was detected by immunohistochemical EliVision two-step method, and its relationship with immunohistochemical subtypes and clinicopathological features was analyzed. Results the total positive rate of PD-L1 in breast cancer cells was 35.3g, especially the highest positive rate in tri-negative breast cancer cells, and the positive rate was in lumen type. The positive rates of HER-2 overexpression type and triple negative type breast cancer cell were 16.1and 37.5 respectively, the difference was statistically significant. The total positive rate of PD-L1 in sTIL was 51.5%. The highest positive rate was 81.0 in the three-negative breast cancer. There was a significant difference in the expression of PD-L1 in lumen type, HER-2 overexpression type and triple negative type breast cancer sTIL. The expression of PD-L1 in breast cancer was positively correlated with sTIL expression. Conclusion the expression of PD-L1 in triple negative breast cancer is significantly higher than that in other types of breast cancer. Blocking the PD-L1/PD-1 signaling pathway may be a new strategy of immunotherapy for breast cancer, especially for triple negative breast cancer.
【作者单位】: 安徽省池州市人民医院病理科;
【分类号】:R737.9
本文编号:2389400
[Abstract]:Objective to investigate the expression of programmed death ligand 1 (programmed death ligand-1,PD-L1 in breast cancer tissues and interstitial infiltrating lymphocytes (stromal tumor-infiltrating lymphocyte,sTIL) and its relationship with clinicopathological features. Methods 68 cases of nonspecific invasive breast carcinoma were collected. The expression of PD-L1 protein was detected by immunohistochemical EliVision two-step method, and its relationship with immunohistochemical subtypes and clinicopathological features was analyzed. Results the total positive rate of PD-L1 in breast cancer cells was 35.3g, especially the highest positive rate in tri-negative breast cancer cells, and the positive rate was in lumen type. The positive rates of HER-2 overexpression type and triple negative type breast cancer cell were 16.1and 37.5 respectively, the difference was statistically significant. The total positive rate of PD-L1 in sTIL was 51.5%. The highest positive rate was 81.0 in the three-negative breast cancer. There was a significant difference in the expression of PD-L1 in lumen type, HER-2 overexpression type and triple negative type breast cancer sTIL. The expression of PD-L1 in breast cancer was positively correlated with sTIL expression. Conclusion the expression of PD-L1 in triple negative breast cancer is significantly higher than that in other types of breast cancer. Blocking the PD-L1/PD-1 signaling pathway may be a new strategy of immunotherapy for breast cancer, especially for triple negative breast cancer.
【作者单位】: 安徽省池州市人民医院病理科;
【分类号】:R737.9
【相似文献】
相关期刊论文 前9条
1 王圆;叶剑飞;;三阴型乳腺癌的研究进展[J];中国医疗前沿;2009年03期
2 ;一乳腺癌新型抑癌基因被发现[J];中华妇幼临床医学杂志(电子版);2011年02期
3 李春艳;张晟;刘艳;张瑾;;三阴型乳腺癌159例临床病理特征分析[J];实用癌症杂志;2012年06期
4 王琢;王丽娟;张颖超;徐景伟;;老年三阴型乳腺癌患者和青年患者临床生物学特征对比[J];中国老年学杂志;2013年03期
5 周勇;;三阴型乳腺癌临床病理特征及预后分析[J];检验医学与临床;2014年11期
6 黄青云;叶京明;徐玲;刘倩;赵建新;段学宁;刘荫华;;蒽环类联合紫杉类方案治疗三阴型乳腺癌前瞻性研究[J];中国实用外科杂志;2013年03期
7 张静;李占文;刘纯;张冰;杨华锋;唐鲁兵;范凤凤;;三阴型与非三阴型乳腺癌患者临床特征及保乳手术治疗效果比较[J];中国乡村医药;2013年10期
8 清水汪;王雅杰;;microRNAs与三阴型乳腺癌研究进展[J];医学研究杂志;2010年11期
9 ;[J];;年期
相关重要报纸文章 前1条
1 衣晓峰 乔蕤琳 陈英云;中外专家找到乳腺癌新药物靶点[N];中国医药报;2011年
相关硕士学位论文 前2条
1 王琢;三阴型乳腺癌老年患者和青年患者临床生物学特征对比分析[D];吉林大学;2013年
2 杨德宏;三阴型乳腺癌临床病理和生物学特征及预后因素探讨[D];天津医科大学;2008年
,本文编号:2389400
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2389400.html